Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Interest & Investment Income (2016 - 2025)

Updated

Adaptimmune Therapeutics' Interest & Investment Income came in at $233,000 for Q2 2025, down 83.1% from $1.38 million a year earlier and down 74.4% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Interest & Investment Income (2016 - 2025) Analysis & Trends

Over the trailing twelve months to Jun 30, 2025, Adaptimmune Therapeutics reported Interest & Investment Income of $3.86 million, down 35.8% year-over-year; for FY2024, it came in at $6.6 million, up 10.6% from FY2023.

  • Interest & Investment Income carries a five-year compound annual growth rate of 18.9% (FY2019 to FY2024).
  • Going back by year, Interest & Investment Income was $5.96 million in FY2023 (+286.8%) and $1.54 million in FY2022.
  • The Q2 2025 figure represents the lowest quarterly Interest & Investment Income in data going back to Q3 2016.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 233,000.00
Mar 31, 2025 910,000.00
Jun 30, 2024 1.38 Mn
Mar 31, 2024 1.35 Mn
Sep 30, 2020 2.15 Mn
Jun 30, 2020 1.15 Mn
Mar 31, 2020 730,000.00
Dec 31, 2019 448,000.00
Sep 30, 2019 615,000.00
Jun 30, 2019 757,000.00
Mar 31, 2019 952,000.00
Dec 31, 2018 1.04 Mn
Sep 30, 2018 606,000.00
Jun 30, 2018 540,000.00
Mar 31, 2018 659,000.00
Dec 31, 2017 765,000.00
Sep 30, 2017 705,000.00
Jun 30, 2017 506,000.00
Mar 31, 2017 240,000.00
Sep 30, 2016 289,000.00
API Access

Adaptimmune Therapeutics PLC Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ADAPY&period=max&api_key=YOUR_API_KEY